Drs. Hoff, Ellis, and Abbruzzese have provided a thorough and useful overview of the current status of the two new monoclonal antibodies, cetuximab (Erbitux) and bevacizumab (Avastin), that have recently become available for the treatment of colorectal cancer. In the case of bevacizumab, a very large, randomized, double-blind, placebocontrolled trial has demonstrated that the addition of this m...

Gene-Eden (by polyDNA) is a broad range, natural antiviral supplement that targets viruses during their latent or chronic phase. The development of GeneEden was inspired by Hanan Polansky’s discovery [1] of the Starved Gene phenomenon. According to Polansky, the promoter/enhancer of certain common viruses, such as Epstein Barr Virus (EBV), Cytomegalovirus (CMV), and Herpes Simplex Virus (HSV), ...

The Oncologist 2005;10:320–322 www.TheOncologist.com Correspondence: Herbert Hurwitz, M.D., Room 3802, Duke University Medical Center, Durham, North Carolina 27710, USA. Telephone: 919-681-5257; Fax: 919-684-9712; e-mail: [email protected] Received September 22, 2004; accepted for publication March 11, 2005. ©AlphaMed Press 1083-7159/2005/$12.00/0 Colorectal cancer is the fourth most commonl...

Case Study  Mr. D., a 55-year-old male, presented to the medical oncology service with a diagnosis of stage III adenocarcinoma of the sigmoid colon. He presented 7 weeks post sigmoid colectomy with lymph node resection and was initiated on adjuvant chemotherapy with CAPOX (capecitabine [Xeloda] and oxaliplatin [Eloxatin]). Standard dosing was used: oxaliplatin at 130 mg/m(2) on day 1 and capeci...

Open AccessCCS ChemistryRESEARCH ARTICLE1 Jun 2021Pd(II) and Rh(III) Complexes with Isoquinoline Derivatives Induced Mitochondria-Mediated Apoptotic Autophagic Cell Death in HepG2 Cells Noor Shad Gul†, Taj-Malook Khan†, Yan-Cheng Liu, Muhammad Iqbal Choudhary, Zhen-Feng Chen Hong Liang Gul† State Key Laboratory for Chemistry Molecular Engineering of Medicinal Resources, School Pharmacy, Guangxi...